International Standard Serial Number (ISSN)
publication venue for
A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer.
Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case-control study.
Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study.
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study.
The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1--deficient ovarian tumors and can be exploited to improve treatment response in a mouse model.
A pilot randomized control trial to evaluate pelvic floor muscle training for urinary incontinence among gynecologic cancer survivors.
Endometrial cancer and a family history of cancer.
Comparison of gene expression patterns between avian and human ovarian cancers.
Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
GPR30 predicts poor survival for ovarian cancer.
Summary of the 2015 American Association for Cancer Research (AACR) Annual Meeting.
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.